These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11336973)
1. A comparison of aroclor 1254-induced and uninduced rat liver microsomes to human liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4'-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6beta-hydroxylation. Easterbrook J; Fackett D; Li AP Chem Biol Interact; 2001 May; 134(3):243-9. PubMed ID: 11336973 [TBL] [Abstract][Full Text] [Related]
2. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Eagling VA; Tjia JF; Back DJ Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822 [TBL] [Abstract][Full Text] [Related]
3. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. Wen X; Wang JS; Neuvonen PJ; Backman JT Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802 [TBL] [Abstract][Full Text] [Related]
4. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Kobayashi K; Urashima K; Shimada N; Chiba K Biochem Pharmacol; 2002 Mar; 63(5):889-96. PubMed ID: 11911841 [TBL] [Abstract][Full Text] [Related]
5. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs. Li J; Liu Y; Zhang JW; Wei H; Yang L Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956 [TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes). Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472 [TBL] [Abstract][Full Text] [Related]
7. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2. Yoshimoto K; Echizen H; Chiba K; Tani M; Ishizaki T Br J Clin Pharmacol; 1995 Apr; 39(4):421-31. PubMed ID: 7640150 [TBL] [Abstract][Full Text] [Related]
8. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates. Zhao K; Ding M; Cao H; Cao ZX J Pharm Pharmacol; 2012 Oct; 64(10):1445-51. PubMed ID: 22943175 [TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes. Yao HT; Chang YW; Lan SJ; Yeh TK Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511 [TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9). Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863 [TBL] [Abstract][Full Text] [Related]
11. Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes. Yang J; He MM; Niu W; Wrighton SA; Li L; Liu Y; Li C Br J Clin Pharmacol; 2012 Feb; 73(2):268-84. PubMed ID: 21815912 [TBL] [Abstract][Full Text] [Related]
12. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9. Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509 [TBL] [Abstract][Full Text] [Related]
13. Effect of single-walled carbon nanotubes on cytochrome P450 activity in human liver microsomes in vitro. Asai Y; Sakakibara Y; Inoue R; Inoue R; Nadai M; Katoh M Biopharm Drug Dispos; 2018 May; 39(5):275-279. PubMed ID: 29719052 [TBL] [Abstract][Full Text] [Related]
14. Effect of probucol on cytochrome P450 activities in human liver microsomes. Umehara K; Shimokawa Y; Miyamoto G Biol Pharm Bull; 2002 Aug; 25(8):1112-4. PubMed ID: 12186421 [TBL] [Abstract][Full Text] [Related]
15. Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomes. Umehara K; Shimokawa Y; Miyamoto G Biol Pharm Bull; 2004 Jul; 27(7):1151-3. PubMed ID: 15256760 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes. Kim JH; Kwon SS; Jeong HU; Lee HS Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes. Nakajima M; Ohyama K; Nakamura S; Shimada N; Yamazaki H; Yokoi T Drug Metab Dispos; 1999 Jul; 27(7):792-7. PubMed ID: 10383922 [TBL] [Abstract][Full Text] [Related]
18. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Pearce RE; McIntyre CJ; Madan A; Sanzgiri U; Draper AJ; Bullock PL; Cook DC; Burton LA; Latham J; Nevins C; Parkinson A Arch Biochem Biophys; 1996 Jul; 331(2):145-69. PubMed ID: 8660694 [TBL] [Abstract][Full Text] [Related]
19. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms. Or PM; Lam FF; Kwan YW; Cho CH; Lau CP; Yu H; Lin G; Lau CB; Fung KP; Leung PC; Yeung JH Phytomedicine; 2012 Apr; 19(6):535-44. PubMed ID: 22261394 [TBL] [Abstract][Full Text] [Related]
20. Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes. Niwa T; Shiraga T; Hashimoto T; Kagayama A Biol Pharm Bull; 2004 Jan; 27(1):97-9. PubMed ID: 14709907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]